Using artificial neural networks to accelerate flowsheet optimization for downstream process development
Biotechnology and Bioengineering · 2024-08 · 121 (8) · 2318-2331
DOI: 10.1002/bit.28454 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 31.05.2023. Verfasst von Daphne Keulen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Delft University of Technology, Delft, The Netherlands. Hauptthemen laut MEDLINE: Neural Networks, Computer, Drug Contamination, Chromatography. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline Biologicals S.A. (Belgium).
Abstract (Originalsprache)
An optimal purification process for biopharmaceutical products is important to meet strict safety regulations, and for economic benefits. To find the global optimum, it is desirable to screen the overall design space. Advanced model‐based approaches enable to screen a broad range of the design‐space, in contrast to traditional statistical or heuristic‐based approaches. Though, chromatographic mechanistic modeling (MM), one of the advanced model‐based approaches, can be speed‐limiting for flowsheet optimization, which evaluates every purification possibility (e.g., type and order of purification techniques, and their operating conditions). Therefore, we propose to use artificial neural networks (ANNs) during global optimization to select the most optimal flowsheets. So, the number of flowsheets for final local optimization is reduced and consequently the overall optimization time. Employing ANNs during global optimization proved to reduce the number of flowsheets from 15 to only 3. From these three, one flowsheet was optimized locally and similar final results were found when using the global outcome of either the ANN or MM as starting condition. Moreover, the overall flowsheet optimization time was reduced by 50% when using ANNs during global optimization. This approach accelerates the early purification process design; moreover, it is generic, flexible, and regardless of sample material's type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
- GSK, Technical Research & Development-Microbial Drug Substance, Rixensart, Belgium.
Förderung
- GlaxoSmithKline Biologicals S.A. (Belgium)
Zitieren
APA
Keulen, D., Hagen, E. V., Geldhof, G., Le Bussy, O., Pabst, M., & Ottens, M. (2024). Using artificial neural networks to accelerate flowsheet optimization for downstream process development. Biotechnology and Bioengineering, 121(8), 2318-2331. https://doi.org/10.1002/bit.28454
Vancouver
Keulen D, Hagen EV, Geldhof G, Le Bussy O, Pabst M, Ottens M. Using artificial neural networks to accelerate flowsheet optimization for downstream process development. Biotechnology and Bioengineering. 2024;121(8):2318-2331. doi:10.1002/bit.28454
BibTeX
@article{Keulen2024,
author = {Keulen, Daphne and Hagen, Erik van der and Geldhof, Geoffroy and Le Bussy, Olivier and Pabst, Martin and Ottens, Marcel},
title = {Using artificial neural networks to accelerate flowsheet optimization for downstream process development},
journal = {Biotechnology and Bioengineering},
year = {2024},
volume = {121},
number = {8},
pages = {2318--2331},
doi = {10.1002/bit.28454}
}
EUVIMED